Stock listing

KRX:048410 Hyundai Bioscience Co. Ltd. (현대바이오) 주가

Follow Hyundai Bioscience Co. Ltd. into a list and get an email when it puts out news.

Share price · KRX:048410

₩6,070.00 KRW +20.00 (+0.3%)

Close on Nov 20, 2026

Past year +25.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩6,040.00 – ₩6,390.00 KRWNov 20, 2026
Volume
908,288 sharesNov 20, 2026
Market cap
₩585.8B KRWAt the close on Nov 20, 2026 · price × 96.50M shares outstanding
52-week range
₩4,565.00 – ₩21,500.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩7.09B KRWMedian day 838,579 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Hyundai Bioscience Co. Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:048410 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩6,070.00+20.00+0.3%₩6,250.00₩6,390.00₩6,040.00908,288
₩6,050.00+80.00+1.3%₩5,980.00₩6,370.00₩5,810.00840,223
₩5,970.00-200.00-3.2%₩6,390.00₩6,420.00₩5,930.00868,661
₩6,170.000.000.0%₩6,230.00₩6,440.00₩6,100.00892,411
₩6,170.00+500.00+8.8%₩5,720.00₩6,850.00₩5,720.003,168,547
₩5,670.00-170.00-2.9%₩5,810.00₩5,810.00₩5,570.00424,786
₩5,840.00+290.00+5.2%₩5,530.00₩5,870.00₩5,510.00585,492
₩5,550.00+140.00+2.6%₩5,610.00₩5,750.00₩5,430.00474,605
₩5,410.00-230.00-4.1%₩5,650.00₩5,800.00₩5,400.00672,679
₩5,640.00+210.00+3.9%₩5,010.00₩5,830.00₩5,010.001,042,356
₩5,430.00-20.00-0.4%₩5,520.00₩5,840.00₩5,310.00828,859
₩5,450.00+220.00+4.2%₩5,330.00₩5,450.00₩5,070.00713,414
₩5,230.00-300.00-5.4%₩5,460.00₩5,460.00₩5,210.00594,368
₩5,530.00+160.00+3.0%₩5,370.00₩5,820.00₩5,340.00833,645
₩5,370.00-300.00-5.3%₩5,590.00₩5,650.00₩5,240.001,057,310
₩5,670.00-200.00-3.4%₩5,870.00₩5,910.00₩5,590.00774,194
₩5,870.00+50.00+0.9%₩5,840.00₩6,120.00₩5,790.001,179,192
₩5,820.00-120.00-2.0%₩5,980.00₩6,240.00₩5,720.001,229,814
₩5,940.00-440.00-6.9%₩6,200.00₩6,230.00₩5,820.00863,840
₩6,380.00+220.00+3.6%₩6,100.00₩6,430.00₩6,000.00744,047
₩6,160.00-180.00-2.8%₩6,220.00₩6,330.00₩6,120.00489,422
₩6,340.00-350.00-5.2%₩6,780.00₩6,980.00₩6,210.00888,514
₩6,690.00-120.00-1.8%₩6,740.00₩6,950.00₩6,540.00546,722
₩6,810.00+260.00+4.0%₩6,450.00₩6,970.00₩6,400.00634,211
₩6,550.00+460.00+7.6%₩6,070.00₩6,740.00₩5,990.00836,935
₩6,090.00-340.00-5.3%₩6,200.00₩6,320.00₩5,880.00938,768
₩6,430.00+10.00+0.2%₩6,360.00₩6,570.00₩6,240.00569,156
₩6,420.00+80.00+1.3%₩6,120.00₩6,560.00₩6,050.00833,349
₩6,340.00-590.00-8.5%₩6,870.00₩7,090.00₩6,330.00920,541
₩6,930.00-360.00-4.9%₩7,270.00₩7,340.00₩6,820.001,092,913
₩7,290.00+140.00+2.0%₩7,150.00₩7,420.00₩7,080.001,314,546
₩7,150.00+100.00+1.4%₩7,080.00₩7,380.00₩7,020.00999,361
₩7,050.000.000.0%₩7,070.00₩7,370.00₩7,040.001,195,843
₩7,050.00+150.00+2.2%₩6,900.00₩7,100.00₩6,830.001,269,517
₩6,900.00+70.00+1.0%₩6,930.00₩7,040.00₩6,830.00798,463
₩6,830.00+20.00+0.3%₩6,790.00₩6,900.00₩6,560.00759,075
₩6,810.00-40.00-0.6%₩6,930.00₩7,140.00₩6,810.00784,396
₩6,850.00+20.00+0.3%₩6,830.00₩7,070.00₩6,740.00611,506
₩6,830.00-260.00-3.7%₩7,080.00₩7,250.00₩6,820.001,016,184
₩7,090.00+290.00+4.3%₩6,830.00₩7,110.00₩6,780.00997,885
₩6,800.00+140.00+2.1%₩6,790.00₩6,890.00₩6,680.00884,018
₩6,660.00-150.00-2.2%₩6,800.00₩7,250.00₩6,630.001,199,416
₩6,810.00+390.00+6.1%₩6,420.00₩6,970.00₩6,300.001,633,864
₩6,420.00-190.00-2.9%₩6,470.00₩6,660.00₩6,330.00883,881
₩6,610.00-90.00-1.3%₩6,510.00₩6,780.00₩6,000.001,464,948
₩6,700.00-530.00-7.3%₩7,200.00₩7,200.00₩6,590.001,494,108
₩7,230.00+100.00+1.4%₩7,130.00₩7,650.00₩6,940.002,898,602
₩7,130.00+870.00+13.9%₩6,200.00₩7,730.00₩6,140.0010,090,029
₩6,260.00-20.00-0.3%₩6,280.00₩6,390.00₩6,130.00647,387
₩6,280.00+70.00+1.1%₩6,270.00₩6,410.00₩6,180.00816,303
₩6,210.00+160.00+2.6%₩6,110.00₩6,220.00₩5,780.00874,205
₩6,050.00-30.00-0.5%₩6,200.00₩6,430.00₩5,990.00806,335
₩6,080.00-310.00-4.9%₩6,250.00₩6,350.00₩6,080.00640,629
₩6,390.00-190.00-2.9%₩6,520.00₩6,550.00₩6,330.00627,297
₩6,580.00+40.00+0.6%₩6,470.00₩6,630.00₩6,320.00753,825
₩6,540.00+110.00+1.7%₩6,430.00₩6,570.00₩6,310.00607,613
₩6,430.00-150.00-2.3%₩6,500.00₩6,980.00₩6,330.001,216,840
₩6,580.00+30.00+0.5%₩6,560.00₩6,735.00₩6,380.00933,328
₩6,550.00-110.00-1.7%₩6,660.00₩6,710.00₩6,260.00763,295
₩6,660.00+10.00+0.2%₩6,910.00₩7,070.00₩6,600.00673,364
₩6,650.00-440.00-6.2%₩6,990.00₩6,990.00₩6,590.00686,895
₩7,090.00-70.00-1.0%₩7,440.00₩7,650.00₩7,050.00637,889

Splits

5 splits since 2004 · KRX:048410 · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
72-for-67Split
1-for-10Consolidation
1-for-30Consolidation
2-for-1Split
Ticker
KRX:048410
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

Latest news

All Hyundai Bioscience Co. Ltd. news

Hyundai Bioscience Co. Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in all · newest May 24, 2021 · oldest 2021

Valuation

EV/sales 166× against a median of 26.3×: 4th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩550.2B KRW
P/E
Loss
EV/sales
166×
EV/EBITDA
Negative EBITDA
Price/book
5.7×
Gross margin
−6.6%
Operating margin
−580.1%
Net margin
−861.5%
Debt to equity
0.1×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Hyundai Bioscience Co. Ltd. · KRX:048410US$435.2MUS$408.8Mn/a166×n/a5.7×−861.5%0.1×n/a
CytomX Therapeutics, Inc. · NASDAQ:CTMXUS$442.5MUS$98.96Mn/a7.0×n/a1.6×−609.0%0.0×1.21
Capricor Therapeutics, Inc. · NASDAQ:CAPRUS$441.3MUS$335.9Mn/an/an/a2.1×n/a0.4×0.94
Hansa Biopharma AB · OMXSTO:HNSAUS$440.9MUS$488.0Mn/a26.3×n/an/a−406.5%n/an/a
Shanghai MicuRx Pharmaceutical Co., Ltd. Class A · SSE:688373US$439.3MUS$408.1Mn/a16.2×n/a19.4×−57.0%0.9×n/a
Clarity Pharmaceuticals Ltd. · ASX:CU6US$437.1MUS$239.0Mn/an/an/a3.5×n/a0.0×n/a
Oculis Holding AG · NASDAQ:OCSUS$434.8MUS$184.3Mn/a22,112×n/a1.8×n/a0.0×0.99
Indaptus Therapeutics, Inc. · NASDAQ:INDPUS$433.2MUS$402.6Mn/an/an/a41.9×n/a0.0×1.77
Rznomics Inc. · KRX:476830US$432.5MUS$406.0Mn/an/an/a12.5×n/a0.0×n/a
LongBio Pharma (Suzhou) Co., Ltd. Class H · HKEX:1779US$430.7MUS$402.0Mn/an/an/a20.4×n/a0.0×n/a
Ovid Therapeutics Inc. · NASDAQ:OVIDUS$429.7MUS$305.4Mn/a210×n/a2.2×n/a0.1×1.37
Median of the othersUS$436.0MUS$369.0M26.3×3.5×−406.5%0.0×1.21

Events

QuarterResultsShare move
Q1 2026May 13, 2026 · Before open−7.2%
Q4 2025Mar 16, 2026 · Before open−5.6%
Q3 2025Nov 12, 2025 · Before open+6.3%
Q2 2025Aug 12, 2025 · Before open+0.7%
Q1 2025May 15, 2025 · Before open−1.1%
Q3 2024Nov 12, 2024 · After close−0.9%
Q2 2024Aug 14, 2024 · After close+3.6%
Q1 2024May 16, 2024 · After close+1.4%
Q4 2023Mar 14, 2024 · Before open−1.9%
Q3 2023Nov 14, 2023 · After close−3.4%
All 20 quarters
QuarterResultsShare move
Q2 2023Aug 11, 2023 · After close−9.4%
Q1 2023May 15, 2023 · After close+2.1%
Q4 2022Feb 27, 2023 · After close+2.9%
Q3 2022Nov 14, 2022 · After close+5.4%
Q2 2022Aug 16, 2022 · Before open−2.4%
Q1 2022May 16, 2022 · Before open+1.1%
Q4 2021Feb 24, 2022 · Before open−6.8%
Q3 2021Nov 15, 2021−1.6%
Quarter to Jun 30, 2021Aug 17, 2021+5.7%
Quarter to Mar 31, 2021May 17, 2021−6.9%

Open Events

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue3.52B15.1B9.48B7.85B9.24B12.5B30.1B31.2B32.0B36.1B
Cost of revenue3.27B3.18B4.44B5.17B5.72B5.95B16.0B16.9B17.1B24.1B
Gross profit243.6M11.9B5.04B2.68B3.52B6.56B14.1B14.3B14.8B12.0B
Research and development7.60B3.06B6.40B16.5B4.76B1.97B1.29B1.70B2.05B2.11B
Selling, general and administrative5.44B7.91B7.91B11.8B6.90B6.38B7.61B9.94B10.8B16.4B
Operating income-18.2B791.0M-14.6B-18.0B-17.3B-7.37B2.56B2.15B1.46B-6.96B
Depreciation and amortization1.31B633.8M1.11B1.29B1.48B3.78B3.81B1.82B1.71B982.8M
EBITDA-16.9B1.42B-13.4B-16.7B-15.8B-3.59B6.37B3.97B3.17B-5.98B
Interest expense2.43B2.31B314.6M448.7M3.00B1.13B0000
Income before tax-22.1B-6.93B-14.5B-16.6B-19.8B-8.38B1.29B3.26B1.21B-8.15B
Income tax326.5M178.8M150.2M-8.45M-79.3M
Net income-22.1B-6.93B-14.5B-15.8B-20.1B-8.61B767.2M2.62B1.22B-8.07B
Earnings per share, basic-230.41-87.01-364.25-398.36-518.69-239.6522.1577.6437.40-266.38

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents22.3B3.66B1.81B2.73B9.19B19.2B5.56B3.16B4.85B9.74B
Short-term investments17.7B10.0B16.0B13.0B1.50B2.66B3.00B
Receivables2.32B247.2M446.2M1.28B7.63B11.0B19.4B25.9B22.5B14.9B
Inventory1.14B1.08B2.59B2.95B3.35B4.21B6.08B4.18B5.88B6.66B
Current assets44.0B6.81B15.2B24.0B34.9B41.9B33.3B35.7B36.4B37.7B
Property, plant and equipment6.38B6.07B6.67B7.20B8.37B9.44B10.1B
Total assets130.7B67.7B52.8B67.3B80.5B92.3B63.2B54.0B49.5B53.4B
Accounts payable498.7M555.3M430.5M686.7M191.6M178.2M827.8M389.5M603.8M3.45B
Current liabilities19.5B27.5B6.95B8.38B16.7B9.58B14.5B11.4B18.5B27.9B
Long-term debt0111.1M29.1B1.00B1.50B7.01B
Total debt35.9B5.49B6.04B15.3B
Total liabilities20.0B28.3B7.52B9.09B19.0B41.1B16.2B13.5B18.6B35.2B
Shareholders' equity110.7B39.4B45.3B58.2B61.6B51.2B47.0B40.5B30.9B18.2B
Shares outstanding96.0M79.6M39.8M39.7M38.7M35.9M34.6M33.7M32.6M30.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-17.0B2.26B-6.01B-16.5B-538.5M7.50B9.18B5.01B-3.70B-4.34B
Capital spending-20.2B-2.17B-587.5M-1.54B-3.76B-25.2B-3.07B-7.07B-1.47B-6.98B
Free cash flow-37.2B87.5M-6.60B-18.1B-4.30B-17.7B-4.06B-2.06B-5.16B-11.3B
Cash from investing-19.7B5.18B8.52B-12.4B-26.8B-14.7B-4.63B654.9M-9.98B
Cash from financing19.2B-58.0M1.67B2.99B33.0B7.88B-2.10B-1.75B12.1B
Share buybacks140.0M1.09B3.60B4.45B2.11B
Change in cash18.7B1.84B-920.5M-6.46B-10.0B13.7B2.39B-1.69B-4.89B-2.17B

Open Financials

Cap table

Built by 6ix from Hyundai Bioscience Co. Ltd.’s releases

Common shares
96,503,316
Fully diluted
96,503,316

Fully diluted

LineShares
Common shares96,503,316

Share count over time

CountShares
Nov 22, 202696,503,316

Open Cap table

Shareholders

Big stakes

StakeFiling
씨앤팜Large holding report (5%)

Open Shareholders

Log in to ask 6ix AI your own questions about Hyundai Bioscience Co. Ltd.